RedLeaf Biologics, Inc. — Form D/A
RedLeaf Biologics, Inc. of LEXINGTON, KY, a company, filed a Form D amendment with the SEC on 2016-12-19. The offering totals $167K, of which $5 was reported sold. Industry: Other.
Offering
- Filed: 2016-12-19
- Form: D/A
- Accession: 0001677182-16-000003
- Industry: Other
- Exemptions: 04
- Total offering: $167K
- Amount sold: $5
- Remaining: $167K
- Investors: 1
- Date of first sale: 2016-08-11
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-275657
Issuer
- Name: RedLeaf Biologics, Inc.
- CIK: 0001677182
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 145 GRAHAM AVE., LEXINGTON, KY, 40506
- Phone: 2059100641
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| William True Baker | Director | Lexington, KY |
| Seth Thomas DeBolt | Director | Nicholasville, KY |
| Christopher Somerville | Director | San Francisco, CA |
| Heather Thomas Youngs | Director | San Francisco, CA |
| Seth Thomas DeBolt | Executive Officer | Nicholasville, KY |
| Robert Jordan Wood | Executive Officer | Lexington, KY |
| WILLIAM BAKER | Director | Chicago, IL |
| Seth DeBolt | Director | Lexington, KY |
| Seth DeBolt | Executive Officer | Lexington, KY |
| Chris Somerville | Director | San Diego, CA |
| Heather Youngs | Director | Lexington, KY |
| Jordan Wood | Executive Officer | Lexington, KY |
| Murray Jordan Phimester | Executive Officer | Menlo Park, CA |
Other filings by this issuer (3)
More